Nascent Biotech, Inc. Developing Therapy with Indications for COVID-19
09 avr. 2020 08h30 HE
|
Small Caps Daily
NEW YORK, NY, April 09, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Nascent Biotech, Inc. (OTCQB: NBIO) (the "Company"), a biotechnology company developing proprietary human Monoclonal Antibodies...
Nascent Biotech Founder, Dr. Mark Glassy, Will Present at the Clinical Operation in Oncology Trials Meeting, in San Diego in February
30 janv. 2020 10h00 HE
|
Nascent Biotech, Inc.
SAN DIEGO, CA , Jan. 30, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Nascent Biotech, Inc. (OTCQB: NBIO) founder Dr. Mark C. Glassy will be presenting on “Navigating the Unique Challenges Presented...